Abstract:Background: Gene set analysis methods have played a major role in generating biological interpretations from omics data such as gene expression datasets. However, most methods focus on detecting homogenous pattern changes in mean expression and methods detecting pattern changes in variance remain poorly explored. While a few studies attempted to use gene-level variance analysis, such approach remains under-utilized. When comparing two phenotypes, gene sets with distinct changes in subgroups under one phenotype are overlooked by available methods although they reflect meaningful biological differences between two phenotypes. Multivariate sample-level variance analysis methods are needed to detect such pattern changes. Results: We use ranking schemes based on minimum spanning tree to generalize the Cramer-Von Mises and Anderson-Darling univariate statistics into multivariate gene set analysis methods to detect differential sample variance or mean. We characterize these methods in addition to two methods developed earlier using simulation results with different parameters. We apply the developed methods to microarray gene expression dataset of prednisolone-resistant and prednisolone-sensitive children diagnosed with B-lineage acute lymphoblastic leukemia and bulk RNA-sequencing gene expression dataset of benign hyperplastic polyps and potentially malignant sessile serrated adenoma/polyps. One or both of the two compared phenotypes in each of these datasets have distinct molecular subtypes that contribute to heterogeneous differences. Our results show that methods designed to detect differential sample variance are able to detect specific hallmark signaling pathways associated with the two compared phenotypes as documented in available literature. Conclusions: The results in this study demonstrate the usefulness of methods designed to detect differential sample variance in providing biological interpretations when biologically relevant but heterogeneous changes between two phenotypes are prevalent in specific signaling pathways. Software implementation of the developed methods is available with detailed documentation from Bioconductor package GSAR. The available methods are applicable to gene expression datasets in a normalized matrix form and could be used with other omics datasets in a normalized matrix form with available collection of feature sets.

Gene expression ranking change based single sample pre-disease state detection

A simple pre-disease state prediction method based on variations of gene vector features

Detect the early-warning signals of diseases based on signaling pathway perturbations on a single sample

Uncovering the Pre-Deterioration State during Disease Progression Based on Sample-Specific Causality Network Entropy (SCNE)

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Discrimination of Genetic Biomarkers of Disease through Machine-Learning-Based Hypothesis Testing of Direct SERS Spectra of DNA and RNA

Individual-level analysis of differential expression of genes and pathways for personalized medicine

DNA-based molecular classifiers for the profiling of gene expression signatures

Quantifying Pathological Progression from Single-Cell Data

Non-Parametric Change-Point Method For Differential Gene Expression Detection

Robust biomarker screening from gene expression data by stable machine learning-recursive feature elimination methods

Disease-specific classification using deconvoluted whole blood gene expression

Precise identification of cell states altered in disease using healthy single-cell references

Identification of Monotonically Differentially Expressed Genes across Pathologic Stages for Cancers

Identification of Marker Genes in Infectious Diseases from ScRNA-seq Data Using Interpretable Machine Learning

Improving data interpretability with new differential sample variance gene set tests

STIGMA: Single-cell tissue-specific gene prioritization using machine learning

Robust detection and genotyping of single feature polymorphisms from gene expression data.

Advancing precision medicine through single‐cell sequencing: Insights and implications

Single molecule targeted sequencing for cancer gene mutation detection

Variations in Laboratory Parameters in Prechronic Disease to Determine Disease Occurrence at the Molecular Level